Stop Guessing Your Assays: Fix Validation Mistakes Before They Fail

Why Assay Validation Fails in Practice

Assay validation is supposed to give us confidence that our measurements are accurate, precise, and reliable. Yet in many labs, validation projects end in frustration: the data look good on paper but fail in routine use, or the team spends months chasing specifications that were never realistic. The root cause is almost never a lack of technical skill—it is a failure to treat validation as a structured, hypothesis-driven process rather than a checklist of tasks.

We have seen this pattern repeat across industries, from pharmaceutical quality control to environmental monitoring. A team runs a few precision and accuracy experiments, gets acceptable numbers, and declares the method validated. Then, six months later, the assay starts drifting, or a new analyst gets different results, and everyone scrambles to figure out what went wrong. The problem is not that validation is hard—it is that we guess our way through it, skipping the foundational work that makes results meaningful.

This guide is written for analysts, lab managers, and quality professionals who want to stop guessing and start validating with purpose. We will walk through the most common mistakes, the patterns that actually work, and the tough questions you should ask before you run a single sample. By the end, you will have a framework for designing validation studies that survive real-world conditions.

The Cost of Guessing

When validation is treated as a box-ticking exercise, the consequences are predictable: rejected batches, rework, regulatory observations, and lost time. One team we worked with spent three months validating a chromatography method, only to discover that the system suitability criteria were too tight for the routine lab environment. Every other run failed, and the method had to be re-validated from scratch. The cost was not just the extra months—it was the loss of trust in the data and the team's morale.

Guessing also leads to over-validation: running more experiments than needed, using overly conservative acceptance criteria, or testing parameters that have no impact on the method's fitness for purpose. This wastes resources and creates a false sense of security. The goal of validation is not to prove the method is perfect—it is to understand its limitations and ensure it is fit for its intended use.

Foundations That Most Teams Get Wrong

Before we dive into specific mistakes, we need to clarify what validation actually requires. Many teams confuse validation with verification or qualification, and this confusion leads to misaligned expectations. Validation answers the question: Does this method produce reliable results for its intended purpose? Verification asks: Did we build the method correctly? Qualification asks: Is the instrument working properly? These are different activities, and mixing them up is a common source of failure.

Another foundational mistake is skipping the pre-validation phase. Before you run any accuracy or precision experiments, you should define the method's intended use: what matrix, what concentration range, what level of uncertainty is acceptable? Without this clarity, you cannot design meaningful acceptance criteria. We have seen teams run full validation studies without ever writing down the method's purpose, then struggle to interpret the results.

Defining the Intended Use

The intended use statement is the most important document in validation. It should specify the analyte, matrix, concentration range, and the decision that will be made from the result (e.g., release vs. reject, pass vs. fail). It should also state the required accuracy and precision, often derived from regulatory guidelines or risk-based criteria. Without this, validation becomes a wandering exercise.

For example, a method intended to measure a drug substance in a tablet at 100 mg per dose needs different performance characteristics than a method measuring a trace impurity at 0.1%. The acceptance criteria for accuracy (e.g., recovery 98–102% vs. 80–120%) and precision (RSD ≤ 2% vs. ≤ 15%) will differ dramatically. Teams that ignore this end up with a method that is either over-validated for its purpose or under-validated and risky.

System Suitability vs. Validation

Another common confusion is between system suitability and validation. System suitability checks that the instrument and method are performing correctly at the time of analysis—it is a real-time quality control step. Validation, on the other hand, demonstrates that the method is robust and reproducible over time and across conditions. Many teams incorporate system suitability limits into their validation protocol, but they should be separate: validation tests the method's range and robustness, while system suitability ensures each run is acceptable.

We once saw a team reject a perfectly valid method because the system suitability criteria were set too tightly during validation. The method itself was accurate and precise, but the column efficiency requirement was unrealistic for routine use. The fix was to re-evaluate the system suitability limits based on validation data, not to re-validate the method. Understanding this distinction saves time and frustration.

Patterns That Actually Work

Now that we have cleared up the foundations, let us look at the patterns that lead to successful validation. These are not secrets—they are well-established principles from guidelines like ICH Q2(R1) for pharmaceuticals or EPA methods for environmental analysis. But knowing them is not enough; you have to apply them with judgment.

Start with a Risk Assessment

Not all method parameters are equally important. A risk assessment helps you focus your validation effort on the parameters that matter most. For example, if your method uses a pH-sensitive mobile phase, you should prioritize robustness testing around pH. If the detection wavelength is critical, you should test its tolerance. This approach prevents you from wasting time on parameters that have negligible impact on method performance.

We recommend using a simple risk matrix: for each parameter, estimate its impact on the result (low, medium, high) and the likelihood of variation in routine use. High-impact, high-likelihood parameters get the most validation attention. Low-impact, low-likelihood parameters can be covered by system suitability or ignored. This prioritization makes validation efficient and defensible.

Use a Pre-Validation Protocol

Before you run any experiments, write a pre-validation protocol that specifies: the intended use, the parameters to be tested, the acceptance criteria, the experimental design (number of replicates, concentration levels, etc.), and the statistical methods for analysis. This protocol should be reviewed and approved before execution. It serves as a contract between the analyst and the decision-maker, ensuring that everyone agrees on what success looks like.

A good pre-validation protocol also includes a plan for handling failures. What will you do if accuracy fails at the low end but passes at the high end? Will you re-optimize the method, tighten the range, or accept the limitation? Having these decisions made upfront prevents reactive, ad hoc changes that compromise the validation's integrity.

Anti-Patterns and Why Teams Revert to Them

Even with the best intentions, teams often fall back into counterproductive habits. Understanding these anti-patterns helps you recognize and avoid them.

The 'One-Shot' Validation

This is the most common anti-pattern: running a single set of experiments, getting acceptable results, and declaring the method validated. The problem is that validation is about reproducibility—a single experiment cannot demonstrate that. You need multiple runs across different days, analysts, and instrument setups to prove that the method is robust. One-shot validations are essentially guesses dressed up as data.

Why do teams revert to this? Because it is fast, and it feels like progress. In a busy lab, the pressure to get a method into routine use is strong. But the time saved upfront is lost many times over when the method fails later. The fix is to build in the expectation of multiple runs from the start and to schedule them as part of the project plan.

Cherry-Picking Data

Another anti-pattern is selectively reporting results that meet acceptance criteria while ignoring outliers or failed runs. This happens when teams are under pressure to deliver a validated method, and they rationalize that one bad run was due to an operator error or a temporary instrument issue. While such explanations can be valid, they must be documented and investigated—not swept under the rug.

Cherry-picking data destroys the credibility of the validation. If you exclude a run, you must have a documented reason (e.g., a known instrument malfunction) and you should repeat the experiment. If you cannot explain the failure, it may indicate a real method problem that needs to be fixed. The honest approach is to report all data, including failures, and discuss their implications.

Maintenance, Drift, and Long-Term Costs

Validation is not a one-time event. Once a method is in routine use, it must be monitored for drift and performance changes. Many teams neglect this, assuming that a validated method will remain valid forever. This is a dangerous assumption.

Ongoing Performance Monitoring

The best way to detect drift is to include quality control samples (QCs) in every run and track their results over time using control charts. A trend in QC results—even if within acceptance limits—can signal a developing problem, such as column degradation, reagent lot changes, or instrument wear. Early detection allows you to investigate and correct before the method fails.

We recommend setting alert limits (e.g., ±2 standard deviations) that trigger a review, even if the action limits (±3 standard deviations) have not been exceeded. This proactive approach reduces the risk of unexpected failures and extends the method's useful life. It also provides data for periodic re-validation or method transfer.

When to Re-Validate

Re-validation is needed when there is a significant change to the method, instrument, matrix, or intended use. But what counts as significant? A good rule of thumb is: if the change could affect accuracy, precision, or selectivity, you should at least perform a partial re-validation. For example, changing the column lot for a chromatography method may require a precision and accuracy check, while changing the detection wavelength would require a full re-validation of linearity and range.

Many teams over-revalidate (running full studies for minor changes) or under-revalidate (ignoring changes that matter). A risk-based approach, documented in a change control procedure, helps strike the right balance. The cost of re-validation should be weighed against the risk of using an unverified method.

When Not to Use This Approach

While the structured validation approach we have described works for most analytical methods, there are situations where it is not appropriate. Recognizing these exceptions prevents over-engineering and wasted effort.

Exploratory or Research Methods

In early-stage research, methods are often used to generate hypotheses, not to make pass/fail decisions. Full validation is overkill and can slow down discovery. Instead, use a lighter qualification approach: demonstrate that the method is fit for the current purpose, with minimal documentation. As the method moves toward regulatory use, you can scale up the validation effort.

For example, a method used to screen dozens of compounds for activity does not need the same level of validation as a method used to release a final product. The key is to match the validation rigor to the decision risk. A simple decision matrix can help: if the result will be used for a high-stakes decision (e.g., batch release, patient safety), validate fully. If it is for internal screening only, qualify.

Methods with No Regulatory Guidance

Some methods, especially novel or non-standard ones, have no established validation guidelines. In these cases, you must design your own criteria based on first principles and risk assessment. This is challenging, but it is also an opportunity to think critically about what the method needs to achieve. Avoid the temptation to borrow criteria from unrelated guidelines—they may not be appropriate.

We have seen teams try to apply pharmaceutical validation criteria to environmental methods, leading to unrealistic expectations and wasted effort. Instead, define the required performance based on the data's end use. If the method is used to estimate exposure levels, the required accuracy might be ±30%, not ±2%. Be honest about what is needed, not what looks impressive.

Open Questions and Common Pitfalls

Even with a solid framework, questions arise. Here we address the most frequent ones we encounter.

How Many Replicates Are Enough?

There is no universal answer, but a common guideline is to use at least 6 replicates at each concentration level for precision studies, and at least 3 concentration levels for accuracy. However, the number should be driven by the variability of the method and the desired confidence. If the method is inherently variable (e.g., biological assays), you may need more replicates. A power analysis can help determine the minimum number, but in practice, many teams use historical precedent (e.g., ICH recommends 5–6 replicates for precision). The important thing is to be consistent and document your rationale.

What If My Method Fails Validation?

Failure is not the end—it is information. If a parameter fails, investigate the root cause. Is the method inherently incapable, or did you set the acceptance criteria too tight? Sometimes the criteria are based on wishful thinking rather than the method's actual capability. In that case, re-evaluate the criteria against the intended use. Other times, the method needs optimization: adjust the sample preparation, change the column, or modify the detection conditions. Document the investigation and the corrective actions. A validation that fails and is then corrected is more credible than one that passes by luck.

One pitfall is to lower acceptance criteria without justification. If you relax criteria, you must show that the method still meets the intended use. For example, if your recovery specification was 98–102% but the method consistently gives 95–105%, and that is acceptable for the decision being made, then document the rationale and update the criteria. Do not simply change numbers to make the data pass.

Next Steps: From Guessing to Knowing

By now, you should have a clear picture of where validation goes wrong and how to fix it. But knowledge without action is just information. Here are specific next moves you can implement starting tomorrow.

First, review your current validation protocols. Do they include an intended use statement? If not, write one for each method. Second, check your system suitability criteria—are they based on validation data or on arbitrary numbers? Adjust them to reflect real method performance. Third, implement a control chart for your routine QC samples. Even a simple spreadsheet chart will help you spot trends early. Fourth, create a change control procedure that defines when re-validation is needed. This prevents both over- and under-revalidation. Fifth, schedule a team meeting to discuss the anti-patterns we covered. Awareness is the first step to change.

Validation is not a burden—it is an investment in data quality. When done right, it saves time, money, and frustration. Stop guessing your assays. Start validating with purpose.